Tag: Cash and cash equivalents

Intapp's Q4 earnings and revenue beat estimates, driving shares up 2.9%. Upbeat forecast for fiscal 2025 strengthens investor confidence.

iCAD's Q2 revenue increased by 21% as the company shifts to a cloud-based SaaS model, aiming for enhanced profitability.

Asensus Surgical's Q2 report highlights revenue increase, net loss, and crucial merger vote with KARL STORZ.

PDS Biotech aligns with FDA for Phase 3 trial, reports Q2 2024 financials with reduced net loss and expenses.

Roivant reports strong clinical progress, with significant Phase 3 study completions, revenue growth, and financial strength.

Beyond Meat sees an 8.8% drop in Q2 revenues but boosts margins and reduces expenses. Forecasts positive outlook for 2024.

Sosei Group Corporation announces operational activities and consolidated results, including significant investment, marketing approval, and partnerships. Despite revenue decrease, the ...

Monday.com's impressive Q4 results, including exceeding earnings and revenue expectations, did not prevent a stock slump. However, the company remains ...

Purple Innovation, Inc. completes a refinancing deal to enhance financial flexibility and support its growth strategy, led by Coliseum Capital ...